These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 17067448

  • 1. Urticaria and angioedema in a patient with Behçet's disease treated with adalimumab.
    Sànchez-Cano D, Callejas-Rubio JL, Ortego-Centeno N, Ruiz-Villaverde R.
    Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S128. PubMed ID: 17067448
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Intestinal Behçet's disease: maintenance of remission with adalimumab monotherapy.
    Ariyachaipanich A, Berkelhammer C, Nicola H.
    Inflamm Bowel Dis; 2009 Dec; 15(12):1769-71. PubMed ID: 19177427
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy of switching to adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab.
    Leccese P, Latanza L, D'Angelo S, Padula A, Olivieri I.
    Clin Exp Rheumatol; 2011 Dec; 29(4 Suppl 67):S93. PubMed ID: 21813069
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of infliximab and adalimumab in the treatment of a patient with severe neuro-Behçet's disease.
    Belzunegui J, López L, Paniagua I, Intxausti JJ, Maíz O.
    Clin Exp Rheumatol; 2008 Dec; 26(4 Suppl 50):S133-4. PubMed ID: 19026138
    [No Abstract] [Full Text] [Related]

  • 6. Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab.
    Leccese P, D'Angelo S, Angela P, Coniglio G, Olivieri I.
    Clin Exp Rheumatol; 2010 Dec; 28(4 Suppl 60):S102. PubMed ID: 20868587
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of Behçet's disease with adalimumab].
    Callejas-Rubio JL, Sánchez-Cano D, Ríos-Férnandez R, Ortego-Centeno N.
    Med Clin (Barc); 2008 Oct 04; 131(11):438-9. PubMed ID: 18928730
    [No Abstract] [Full Text] [Related]

  • 9. Adalimumab: a new modality for Behçet's disease?
    van Laar JA, Missotten T, van Daele PL, Jamnitski A, Baarsma GS, van Hagen PM.
    Ann Rheum Dis; 2007 Apr 04; 66(4):565-6. PubMed ID: 17124248
    [No Abstract] [Full Text] [Related]

  • 10. Angioedema occurring in pediatric patients with Crohn disease treated with adalimumab.
    Adamiak T, Stephens M, Werlin SL.
    J Pediatr Gastroenterol Nutr; 2010 Aug 04; 51(2):223-5. PubMed ID: 20410840
    [No Abstract] [Full Text] [Related]

  • 11. [Adalimumab-induced urticaria].
    Mallo S, Santos-Juanes J.
    Actas Dermosifiliogr; 2007 Sep 04; 98(7):511-2. PubMed ID: 17669313
    [No Abstract] [Full Text] [Related]

  • 12. Tuberculosis and Legionella pneumophila pneumonia in a patient receiving anti-tumour necrosis factor-alpha (anti-TNF-alpha) treatment.
    Mancini G, Erario L, Gianfreda R, Oliva A, Massetti AP, Mastroianni CM, Vullo V.
    Clin Microbiol Infect; 2007 Oct 04; 13(10):1036-7. PubMed ID: 17711485
    [No Abstract] [Full Text] [Related]

  • 13. Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet's Disease.
    Park J, Cheon JH.
    Gut Liver; 2018 Nov 15; 12(6):623-632. PubMed ID: 29788675
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of adalimumab in patients with Behçet's disease unsuccessfully treated with infliximab.
    Olivieri I, Leccese P, D'Angelo S, Padula A, Nigro A, Palazzi C, Coniglio G, Latanza L.
    Clin Exp Rheumatol; 2011 Nov 15; 29(4 Suppl 67):S54-7. PubMed ID: 21968237
    [Abstract] [Full Text] [Related]

  • 15. Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab.
    Haennig A, Bonnet D, Thebault S, Alric L.
    Gastroenterol Clin Biol; 2010 Sep 15; 34(8-9):e7-8. PubMed ID: 20189334
    [No Abstract] [Full Text] [Related]

  • 16. [Efficacy of adalimumab in Behçet's disease. Description of 6 cases].
    Calvo Catalá J, Campos Fernández C, Rueda Cid A, González-Cruz Cervellera MI, Baixauli Rubio A, Pastor Cubillo MD.
    Reumatol Clin; 2011 Sep 15; 7(4):258-61. PubMed ID: 21794828
    [Abstract] [Full Text] [Related]

  • 17. Adalimumab-induced urticaria.
    George SJ, Anderson HL, Hsu S.
    Dermatol Online J; 2006 Feb 28; 12(2):4. PubMed ID: 16638397
    [No Abstract] [Full Text] [Related]

  • 18. Adalimumab-induced psoriasis of the scalp with diffuse alopecia: a severe potentially irreversible cutaneous side effect of TNF-alpha blockers.
    El Shabrawi-Caelen L, La Placa M, Vincenzi C, Haidn T, Muellegger R, Tosti A.
    Inflamm Bowel Dis; 2010 Feb 28; 16(2):182-3. PubMed ID: 19462433
    [No Abstract] [Full Text] [Related]

  • 19. Adalimumab desensitization protocol in a patient with a generalized urticarial reaction and angioedema following adalimumab administration.
    Gutiérrez Fernández D, Foncubierta Fernández A, Anguita Carazo JL, Fernández Meléndez S, Fernández Anguita MJ, Medina Varo F.
    J Investig Allergol Clin Immunol; 2014 Feb 28; 24(4):273-5. PubMed ID: 25219112
    [No Abstract] [Full Text] [Related]

  • 20. Clinical experience with adalimumab in the treatment of ocular Behçet disease.
    Bawazeer A, Raffa LH, Nizamuddin SH.
    Ocul Immunol Inflamm; 2010 Jun 28; 18(3):226-32. PubMed ID: 20482404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.